The Role of S-Glutathionylation in Health and Disease: A Bird's Eye View

被引:1
作者
Federici, Luca [1 ,2 ]
Masulli, Michele [1 ]
De Laurenzi, Vincenzo [1 ,2 ]
Allocati, Nerino [1 ]
机构
[1] Univ G dAnnunzio, Dept Innovat Technol Med & Dent, Unit Prostodont, I-66100 Chieti, Italy
[2] Univ G dAnnunzio, CAST Ctr Adv Studies & Technol, I-66100 Chieti, Italy
关键词
glutathione; GSH; S-glutathionylation; GS-ylation; oxidative stress; post-translational modification; VASCULAR ENDOTHELIAL-CADHERIN; CYSTATHIONINE BETA-SYNTHASE; OXIDATIVE STRESS; PROTEIN GLUTATHIONYLATION; REDOX REGULATION; TRANSFERASE-PI; POTENTIAL ROLE; HUMAN P53; BRAIN; MECHANISMS;
D O I
10.3390/nu16162753
中图分类号
R15 [营养卫生、食品卫生]; TS201 [基础科学];
学科分类号
100403 ;
摘要
Protein glutathionylation is a reversible post-translational modification that involves the attachment of glutathione to cysteine residues. It plays a role in the regulation of several cellular processes and protection against oxidative damage. Glutathionylation (GS-ylation) modulates protein function, inhibits or enhances enzymatic activity, maintains redox homeostasis, and shields several proteins from irreversible oxidative stress. Aberrant GS-ylation patterns are thus implicated in various diseases, particularly those associated with oxidative stress and inflammation, such as cardiovascular diseases, neurodegenerative disorders, cancer, and many others. Research in the recent years has highlighted the potential to manipulate protein GS-ylation for therapeutic purposes with strategies that imply both its enhancement and inhibition according to different cases. Moreover, it has become increasingly evident that monitoring the GS-ylation status of selected proteins offers diagnostic potential in different diseases. In this review, we try to summarize recent research in the field with a focus on our current understanding of the molecular mechanisms related to aberrant protein GS-ylation.
引用
收藏
页数:22
相关论文
共 141 条
  • [1] The development of proteasome inhibitors as anticancer drugs
    Adams, J
    [J]. CANCER CELL, 2004, 5 (05) : 417 - 421
  • [2] Glutathione transferases: substrates, inihibitors and pro-drugs in cancer and neurodegenerative diseases
    Allocati, Nerino
    Masulli, Michele
    Di Ilio, Carmine
    Federici, Luca
    [J]. ONCOGENESIS, 2018, 7
  • [3] ANTTILA S, 1993, CANCER RES, V53, P5643
  • [4] Glutathione: new roles in redox signaling for an old antioxidant
    Aquilano, Katia
    Baldelli, Sara
    Ciriolo, Maria R.
    [J]. FRONTIERS IN PHARMACOLOGY, 2014, 5
  • [5] Oxidation of glyceraidehyde-3-phosphate dehydrogenase enhances its binding to nucleic acids
    Arutyunova, EI
    Danshina, PV
    Domnina, LV
    Pleten, AP
    Muronetz, VI
    [J]. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2003, 307 (03) : 547 - 552
  • [6] Protein Kinase C Life Cycle: Explained Through Systems Biology Approach
    Aslam, Naveed
    Alvi, Farah
    [J]. FRONTIERS IN PHYSIOLOGY, 2022, 13
  • [7] SERS-based detection of 5-S-cysteinyl-dopamine as a novel biomarker of Parkinson's disease in artificial biofluids
    Badillo-Ramirez, Isidro
    Landeros-Rivera, Bruno
    Saniger, Jose M.
    Popp, Juergen
    Cialla-May, Dana
    [J]. ANALYST, 2023, 148 (08) : 1848 - 1857
  • [8] 5-S-cysteinyl-dopamine, a neurotoxic endogenous metabolite of dopamine: Implications for Parkinson's disease
    Badillo-Ramirez, Isidro
    Saniger, Jose M.
    Rivas-Arancibia, Selva
    [J]. NEUROCHEMISTRY INTERNATIONAL, 2019, 129
  • [9] Small Molecules as SIRT Modulators
    Bai, Xinfa
    Yao, Lei
    Ma, Xuan
    Xu, Xiangming
    [J]. MINI-REVIEWS IN MEDICINAL CHEMISTRY, 2018, 18 (13) : 1151 - 1157
  • [10] Cysteine reactivity across the subcellular universe
    Bak, Daniel W.
    Bechtel, Tyler J.
    Falco, Julia A.
    Weerapana, Eranthie
    [J]. CURRENT OPINION IN CHEMICAL BIOLOGY, 2019, 48 : 96 - 105